Tenax Therapeutics (TENX) Enterprise Value (QoQ) (2010 - 2026)

Tenax Therapeutics (TENX) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tenax Therapeutics 67,856.40 67,856.40 -

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.72%
Dec 31, 2025 1.82%
Sep 30, 2025 5.78%
Jun 30, 2025 5.37%
Mar 31, 2025 -17.50%
Dec 31, 2024 3.52%
Sep 30, 2024 -947.64%
Jun 30, 2024 25.22%
Mar 31, 2024 -28.16%
Dec 31, 2023 12.11%
Sep 30, 2023 16.82%
Jun 30, 2023 7.08%
Mar 31, 2023 -578.66%
Dec 31, 2022 44.20%
Sep 30, 2022 47.35%
Jun 30, 2022 -152.00%
Mar 31, 2022 48.63%
Dec 31, 2021 33.16%
Sep 30, 2021 -282.80%
Jun 30, 2021 45.87%